Breast cancer in association with thyroid disorders

Journal of B.U.ON.

Volumn 14, Issue 3, 2009, Pages 425-428

  Michalaki, V ^a   Kondi Pafiti, A ^a   Gennatas, S ^a   Antoniou, A ^a   Primetis, H ^a   Gennatas, C ^a   Gennatas, Konstantinos ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE

Author keywords

Breast cancer; Hormonal therapy; Thyroiditis

Indexed keywords

AUTOANTIBODY; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN; THYROGLOBULIN ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE; THYROTROPIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FREE THYROXINE INDEX; HORMONAL THERAPY; HUMAN; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MENOPAUSE; THYROID DISEASE; THYROID FUNCTION TEST; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; ULTRASOUND;

ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNITY; BREAST NEOPLASMS; FEMALE; GREECE; HUMANS; INCIDENCE; MIDDLE AGED; PEROXIDASE; THYROID DISEASES; THYROID GLAND; THYROID HORMONES;

EID: 70350076885     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Rasmussen B, Rasmussen UF, Hegedus L, Perrild H, Bech K, Hoier-Madsen M. Thyroid function in patients with breast cancer. J Cancer Clin Oncol 1987; 23: 553-556. (Pubitemid 17057387)
2. Shering SG, Zbar AP, Moriatry M. Thyroid disorders and breast cancer. Eur J Cancer Prev 1996; 5: 504-506.
3. Gogas J, Kouskos E, Tseleni-Balafouta S et al. Autoimmune thyroid disease in women with breast carcinoma. Eur J Surg Oncol 2001; 27: 626-630. (Pubitemid 33062168)
4. Lemmarie M, Baugnet-Mahieu L. Thyroid function in women with breast cancer. Eur J Cancer Clin Oncol 1986; 22: 301-307.
5. Smyth PP, Shering SG, Kilbane MT et al. Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metabol 1998; 83: 2711-2716.
6. Giustarini E, Pinchera A, Fierabracci P et al. Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 2006; 154: 645-649. (Pubitemid 43810849)
7. Mamby CC, Love RR, Lee KE. Thyroid function test changes with adjuvant tamoxifen therapy in postmenopausal women with breast cancer. J Clin Oncol 1995; 13: 854-857.
8. Anker GB, Lønning PE, Aakvaag A, Lien EA. Thyroid function in postmenopausal breast cancer patients treated with tamoxifen. Scand J Clin Lab Invest 1998; 58: 103-107. (Pubitemid 28185378)
9. Gordon D, Beastall GH, McArdle CS, Thomson JA. The effect of tamoxifen therapy on thyroid function tests. Cancer 1986; 58: 1422-1425.
10. Fex G, Adielsson G, Mattson W. Oestrogen-like effects of tamoxifen on the concentration of proteins in plasma. Acta Endocrinol 1981; 97: 109-113. (Pubitemid 11074375)
11. Pannuti F, Ciovannini M, Martoni A et al. Tamoxifen-induced effects on T3, T4, TSH, LH, hPRL, 17-O-estradiol, testosterone and aldosterone plasma levels: A preliminary study. IRCS Med Sci 1981; 9: 156.
12. Smyth PP. Thyroid disease and breast cancer. J Endocrinol Invest 1993; 16: 396-401.
13. Giani C, Fierabracci P, Bonacci R et al. Relationship between breast cancer and thyroid disease: Relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metabol 1996; 81: 990-994. (Pubitemid 26083958)
14. Cengiz O, Bozkur B, Unal B et al. The relationship between prognostic factors of breast cancer and thyroid disorders in Turkish women. J Surg Oncol 2004; 87: 19-25. (Pubitemid 38880275)